Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01945060 · ClinicalTrials.gov registry record · NA
Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator
A NA study, sponsored by Marc Breton.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01945060 is a NA study that has completed, run by Marc Breton. The registered enrollment target is 22 participants.
The verdict
NCT01945060, a NA study, has completed, sponsored by Marc Breton.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to see if the Artificial Pancreas (AP) Platform can successfully control blood sugar in people with type 1 diabetes mellitus on insulin pump therapy in a hospital setting. Investigators will also be studying to see if the heart rate informed Control To Range (hrCTR) can improve the performance of the system during and immediately after exercise.
Interventions
- DEVICE heart rate Control to Range System (hrCTR) using DiAs Platform
- OTHER DiAs Control-to-Range System not informed for heart rate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01945060
The ClinicalTrials.gov registry entry for NCT01945060 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marc Breton, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which heart rate Control to Range System (hrCTR) using DiAs Platform is the first listed.
NCT01945060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01945060 about?
NCT01945060 is a clinical study titled "Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator". The purpose of this study is to see if the Artificial Pancreas (AP) Platform can successfully control blood sugar in people with type 1 diabetes mellitus on insulin pump therapy in a hospital setting. Investigators will also be studying to see if the heart rate informed Control To Range (hrCTR) can ...
What is the current status of trial NCT01945060?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2013-09. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01945060?
The interventions under investigation include: heart rate Control to Range System (hrCTR) using DiAs Platform (DEVICE), DiAs Control-to-Range System not informed for heart rate (OTHER).
Who is sponsoring clinical trial NCT01945060?
This trial is sponsored by Marc Breton, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.